Literature DB >> 1353517

Taxol, a microtubule-stabilizing antineoplastic agent, induces expression of tumor necrosis factor alpha and interleukin-1 in macrophages.

C Bogdan1, A Ding.   

Abstract

Taxol, a naturally occurring diterpene with antitumor activity, induces tubulin polymerization to generate abnormally stable and nonfunctional microtubules. Previously, we showed that taxol has lipopolysaccharide (LPS)-like effects on macrophages. As LPS is a potent inducer of macrophage cytokine production, we investigated whether a similar effect is exerted by taxol. In a dose-dependent manner, LPS-free taxol induced release of biologically active tumor necrosis factor alpha (TNF) by inflammatory murine macrophages. Taxol-induced production of TNF was inhibitable by interleukin-10. By Northern blot, taxol (10 and 1 microM) induced TNF mRNA expression to an extent similar to LPS. Induction of TNF mRNA by 10 microM taxol was detectable at 45 min of stimulation, maximal at 90 min, and evident for at least 8 h. The same low concentration of taxol also induced interleukin 1 (IL-1) alpha and beta mRNA expression. We conclude that taxol triggers macrophages for TNF and IL-1 production. These LPS-like effects of taxol might contribute to its antitumor activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1353517     DOI: 10.1002/jlb.52.1.119

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  33 in total

1.  Identification of tumor-specific paclitaxel (Taxol)-responsive regulatory elements in the interleukin-8 promoter.

Authors:  L F Lee; J S Haskill; N Mukaida; K Matsushima; J P Ting
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  p53-independent apoptosis induced by paclitaxel through an indirect mechanism.

Authors:  J S Lanni; S W Lowe; E J Licitra; J O Liu; T Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

3.  Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats.

Authors:  Annemarie Ledeboer; Brian M Jekich; Evan M Sloane; John H Mahoney; Stephen J Langer; Erin D Milligan; David Martin; Steven F Maier; Kirk W Johnson; Leslie A Leinwand; Raymond A Chavez; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2006-12-15       Impact factor: 7.217

4.  Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor.

Authors:  F Jin; C F Nathan; D Radzioch; A Ding
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

5.  Heparanase and Chemotherapy Synergize to Drive Macrophage Activation and Enhance Tumor Growth.

Authors:  Udayan Bhattacharya; Lilach Gutter-Kapon; Tal Kan; Ilanit Boyango; Uri Barash; Shi-Ming Yang; JingJing Liu; Miriam Gross-Cohen; Ralph D Sanderson; Yuval Shaked; Neta Ilan; Israel Vlodavsky
Journal:  Cancer Res       Date:  2019-11-05       Impact factor: 12.701

6.  Docetaxel-induced nail changes--a neurogenic mechanism: a case report.

Authors:  Gunnar Wasner; Felix Hilpert; Jörn Schattschneider; Andreas Binder; Jacobus Pfisterer; Ralf Baron
Journal:  J Neurooncol       Date:  2002-06       Impact factor: 4.130

7.  Paclitaxel ameliorates lipopolysaccharide-induced kidney injury by binding myeloid differentiation protein-2 to block Toll-like receptor 4-mediated nuclear factor-κB activation and cytokine production.

Authors:  Dongshan Zhang; Yijian Li; Yu Liu; Xudong Xiang; Zheng Dong
Journal:  J Pharmacol Exp Ther       Date:  2013-01-14       Impact factor: 4.030

8.  Immunomodulatory effects of docetaxel on human lymphocytes.

Authors:  Ming-Sing Si; David K Imagawa; Ping Ji; Xunbin Wei; Bari Holm; Jennifer Kwok; Michael Lee; Bruce A Reitz; Dominic C Borie
Journal:  Invest New Drugs       Date:  2003-08       Impact factor: 3.850

9.  Effects of a pyrrole-based, microtubule-depolymerizing compound on RAW 264.7 macrophages.

Authors:  John A Ciemniecki; Clarke P Lewis; John T Gupton; Krista Fischer-Stenger
Journal:  Chem Biol Interact       Date:  2016-01-11       Impact factor: 5.192

10.  Microtubule-interacting drugs induce moderate and reversible damage to human bone marrow mesenchymal stem cells.

Authors:  H Polioudaki; M-C Kastrinaki; H A Papadaki; P A Theodoropoulos
Journal:  Cell Prolif       Date:  2009-05-22       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.